Добро пожаловать
Нажатие «Авторизоваться» означает, что вы соглашаетесь с Условия использования и политика конфиденциальности Cointime.
Зарегистрировать аккаунт
Аккаунт уже существует?
Нажатие «page.Sign up» означает, что вы соглашаетесь с <a class="underline" href="#term-of-service">Условия использования</a> и a class="underline" href="#privacy-policy">политика конфиденциальности</a> Cointime.
Войдите, используя email
Зарегистрируйтесь с помощью email
твой почтовый ящик
Проверь свои входящие
Нажмите на ссылку в , чтобы войти.
Нажмите на ссылку в , чтобы зарегистрироваться.
Omeros
company
About
Omeros is a clinical-stage biopharmaceutical company developing products focused on inflammation and central nervous system disorders.
- 101 - 250
Details
- Last Funding Type
- Series E
- Last Funding Money Raised
- $63M
- Industries
- Biotechnology,Health Care,Pharmaceutical
- Founded date
- Jan 1, 1994
- Number Of Employee
- 101 - 250
- Operating Status
- Active
Omeros is a Seattle-based commercial-stage biopharmaceutical company committed to discovering, developing, and commercializing small-molecule and protein therapeutics for large-market as well as orphan indications targeting inflammation, complement-mediated diseases and disorders of the central nervous system.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
2
$103M
Omeros has raised a total of
$103M
in funding over 2 rounds. Their latest funding was raised on
Jul 29, 2010 from a Post-IPO Equity round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Jul 29, 2010 | Post-IPO Equity | $40M | 1 |
|
— | Detail |
| Feb 12, 2007 | Series E | $63M | 1 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
1
2
Omeros is funded by 2 investors.
Azimuth Opportunity
and ARCH Venture Partners
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
|
Yes | Post-IPO Equity |
ARCH Venture Partners
|
— | Series E |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
